MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century
暂无分享,去创建一个
Carlos Cordon-Cardo | C. Cordon-Cardo | S. Siddiqi | I. Matushansky | Todd Hricik | Todd Hricik | Elizabeth Charytonowicz | Igor Matushansky | Joslyn Mills | Sara Siddiqi | E. Charytonowicz | Joslyn Mills
[1] P. Meltzer,et al. Focus on sarcomas. , 2002, Cancer cell.
[2] S. Daugaard. Current soft-tissue sarcoma classifications. , 2004, European journal of cancer.
[3] D. Prockop,et al. The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone Marrow* , 2003, Journal of Biological Chemistry.
[4] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[5] N. Socci,et al. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. , 2008, The American journal of pathology.
[6] S. Weiss. Malignant fibrous histiocytoma. A reaffirmation. , 1982, The American journal of surgical pathology.
[7] C. Fletcher. Pleomorphic Malignant Fibrous Histiocytoma: Fact or Fiction? A Critical Reappraisal Based on 159 Tumors Diagnosed as Pleomorphic Sarcoma , 1992, The American journal of surgical pathology.
[8] F. Enzinger. Malignant fibrous histiocytoma 20 years after Stout. , 1986, The American journal of surgical pathology.
[9] L. Layfield,et al. Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis. , 2004, American journal of orthopedics.
[10] N. Cordani,et al. Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts. , 2003, International journal of oncology.
[11] E. E. Gresch. Genetic Alterations During Colorectal-Tumor Development , 1989 .
[12] J. C. Ivins,et al. Malignant fibrous histiocytoma a retrospective study of 167 cases , 1980, Cancer.
[13] R. Tuan,et al. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.
[14] D. Ettinger,et al. The use of chemotherapy in soft-tissue sarcomas. , 2002, The oncologist.
[15] L. Dehner. Malignant fibrous histiocytoma. Nonspecific morphologic pattern, specific pathologic entity, or both? , 1988, Archives of pathology & laboratory medicine.
[16] A. D. Dei Tos. Classification of pleomorphic sarcomas: where are we now? , 2006, Histopathology.
[17] Y. Takakura,et al. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. , 2009, International journal of oncology.
[18] B. Johansson,et al. The impact of translocations and gene fusions on cancer causation , 2007, Nature Reviews Cancer.
[19] A. Stout,et al. Cultural characteristics of malignant histiocytomas and fibrous xanthomas , 1963, Cancer.
[20] R. Kutner,et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies , 2007, British Journal of Cancer.
[21] C. Cordon-Cardo,et al. A context dependent role for Wnt signaling in tumorigenesis and stem cells , 2008, Cell cycle.
[22] N. Socci,et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. , 2007, The Journal of clinical investigation.
[23] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[24] P. Lucas,et al. Wnt10b Inhibits Development of White and Brown Adipose Tissues* , 2004, Journal of Biological Chemistry.
[25] G. Daley,et al. From fibroblasts to iPS cells: Induced pluripotency by defined factors , 2008, Journal of cellular biochemistry.
[26] R. Sylvester,et al. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997 .
[27] I. Sesterhenn,et al. Pathology of germ cell tumors of the testis. , 2004, Cancer control : journal of the Moffitt Cancer Center.
[28] Walter Birchmeier,et al. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. , 2005, Developmental cell.
[29] S. Weiss,et al. Malignant fibrous histiocytoma. An Analysis of 200 Cases , 1978 .
[30] J. Eary,et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] O. Delattre,et al. CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases. , 2001, Cancer genetics and cytogenetics.
[32] S. Devesa,et al. Cutaneous soft tissue sarcoma incidence patterns in the U.S. , 2008, Cancer.
[33] Hans Clevers,et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. , 2005, Developmental cell.
[34] P. D. Dal Cin,et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. , 2002, Cancer Research.
[35] K. Itoh,et al. Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells. , 2007, European journal of cancer.
[36] R. Pochampally,et al. Isolation of a Highly Clonogenic and Multipotential Subfraction of Adult Stem Cells from Bone Marrow Stroma , 2004, Stem cells.
[37] D. Crowther. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.
[38] D. Prockop,et al. Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.
[39] M. Murphey,et al. World Health Organization Classification of Bone and Soft Tissue Tumors: Modifications and Implications for Radiologists , 2007, Seminars in musculoskeletal radiology.
[40] M. Tsuneyoshi,et al. Malignant Fibrous Histiocytoma , 1980, Virchows Archiv A.
[41] Mikhail Teverovskiy,et al. Improved prediction of prostate cancer recurrence through systems pathology. , 2007, The Journal of clinical investigation.
[42] R. Cancedda,et al. Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds. , 2009, Carcinogenesis.
[43] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[44] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[45] R. Hustinx,et al. Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] S. Armstrong,et al. Cancer Stem Cells in Hematopoietic Malignancies. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[47] C. Fletcher. Pleomorphic Malignant Fibrous Histiocytoma: Fact or Fiction? A Critical Reappraisal Based on 159 Tumors Diagnosed as Pleomorphic Sarcoma , 1992, The American journal of surgical pathology.
[48] T O Nielsen,et al. MicroRNA expression signature of human sarcomas , 2008, Oncogene.
[49] H. Broxmeyer,et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.
[50] D. Albertson,et al. Chromosome aberrations in solid tumors , 2003, Nature Genetics.
[51] A. Órfão,et al. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. , 1999, Clinical chemistry.
[52] William Stafford Noble,et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. , 2003, The American journal of pathology.
[53] J. Komorowski,et al. Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm , 2005, Clinical Cancer Research.
[54] L. Bélanger. [Differentiation and cancer]. , 1985, L'union medicale du Canada.
[55] Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC). , 2000, The Cochrane database of systematic reviews.
[56] Edward W Scott,et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.
[57] R. Maki,et al. Mechanisms of sarcomagenesis. , 2005, Hematology/oncology clinics of North America.
[58] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[59] A. Bahrami,et al. An overview of testicular germ cell tumors. , 2009, Archives of pathology & laboratory medicine.
[60] Catherine M. Verfaillie,et al. The molecular repertoire of the 'almighty' stem cell , 2005, Nature Reviews Molecular Cell Biology.
[61] K. Hochedlinger,et al. Epigenetic reprogramming and induced pluripotency , 2009, Development.
[62] M. Tsuneyoshi,et al. Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases. , 1980, Acta pathologica japonica.
[63] S. Chin,et al. FUS/ERG gene fusions in Ewing's tumors. , 2003, Cancer research.
[64] C. Fletcher. The evolving classification of soft tissue tumours: an update based on the new WHO classification , 2006, Histopathology.